| NCT06699680 | Phase 1 Study of PRX019 in Healthy Adult Volunteers | RECRUITING | PHASE1 | 2024-11-08 | 2026-01-23 | 2026-01-23 |
| NCT04973137 | A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis | TERMINATED | PHASE3 | 2021-08-30 | 2025-06-20 | 2025-04-02 |
| NCT03336580 | A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis | TERMINATED | PHASE1 | 2018-04-05 | 2020-07-23 | 2020-07-23 |
| NCT03154047 | Study in Subjects With Light Chain (AL) Amyloidosis | TERMINATED | PHASE2 | 2017-06-14 | 2018-05-30 | 2018-05-30 |
| NCT02630901 | Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis | COMPLETED | PHASE1 | 2016-03-17 | 2018-02-28 | 2018-02-28 |
| NCT02632786 | The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis | COMPLETED | PHASE2 | 2016-03 | 2018-03 | 2018-03 |
| NCT02613182 | Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis | TERMINATED | PHASE2 | 2016-02 | 2018-05 | 2018-05 |
| NCT02458677 | Single Ascending Dose Study of PRX003 in Healthy Subjects | COMPLETED | PHASE1 | 2015-05 | 2016-02 | 2016-02 |
| NCT02312206 | The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis | TERMINATED | PHASE3 | 2015-02 | 2018-05 | 2018-05 |
| NCT02157714 | Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease | COMPLETED | PHASE1 | 2014-06 | | 2016-09 |
| NCT02095171 | Single Ascending Dose Study of PRX002 in Healthy Subjects | COMPLETED | PHASE1 | 2014-03 | | 2014-12 |
| NCT01707264 | Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis | COMPLETED | PHASE1, PHASE2 | 2013-04 | 2016-08-09 | 2016-08-09 |